financetom
Business
financetom
/
Business
/
U.S. FDA accepts Novo Nordisk's application for oral Wegovy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
U.S. FDA accepts Novo Nordisk's application for oral Wegovy
May 26, 2025 12:35 AM

May 2 (Reuters) - The U.S. Food and Drug Administration

has accepted Novo Nordisk's marketing application for

the experimental once-daily oral version of its blockbuster

weight-loss drug Wegovy, the Danish drugmaker said on Friday.

(Reporting by Sriparna Roy in Bengaluru; Editing by Sriraj

Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved